Skip to main content
PMC home page
Gut logoLink to Gut
. 1985 May;26(5):433–437. doi: 10.1136/gut.26.5.433

New somatostatin molecule for management of endocrine tumours.

S Bonfils
PMCID: PMC1432656  PMID: 2860051

Full text

PDF
437

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloom S. R., Mortimer C. H., Thorner M. O., Besser G. M., Hall R., Gomez-Pan A., Roy V. M., Russell R. C., Coy D. H., Kastin A. J. Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet. 1974 Nov 9;2(7889):1106–1109. doi: 10.1016/s0140-6736(74)90869-1. [DOI] [PubMed] [Google Scholar]
  2. Curnow R. T., Carey R. M., Taylor A., Johanson A., Murad F. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. N Engl J Med. 1975 Jun 26;292(26):1385–1386. doi: 10.1056/NEJM197506262922606. [DOI] [PubMed] [Google Scholar]
  3. Davis G. R., Camp R. C., Raskin P., Krejs G. J. Effect of somatostatin infusion on jejunal water and electrolyte transport in a patient with secretory diarrhea due to malignant carcinoid syndrome. Gastroenterology. 1980 Feb;78(2):346–349. [PubMed] [Google Scholar]
  4. Dharmsathaphorn K., Sherwin R. S., Cataland S., Jaffe B., Dobbins J. Somatostatin inhibits diarrhea in the carcinoid syndrome. Ann Intern Med. 1980 Jan;92(1):68–69. doi: 10.7326/0003-4819-92-1-68. [DOI] [PubMed] [Google Scholar]
  5. Efendić S., Mattsson O. Effect of somatostatin on intestinal motility. Acta Radiol Diagn (Stockh) 1978;19(2):348–352. doi: 10.1177/028418517801900209. [DOI] [PubMed] [Google Scholar]
  6. Frölich J. C., Bloomgarden Z. T., Oates J. A., McGuigan J. E., Rabinowitz D. The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med. 1978 Nov 9;299(19):1055–1057. doi: 10.1056/NEJM197811092991908. [DOI] [PubMed] [Google Scholar]
  7. Krejs G. J., Browne R., Raskin P. Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes. Gastroenterology. 1980 Jan;78(1):26–31. [PubMed] [Google Scholar]
  8. Lehy T., Dubrasquet M., Brazeau P., Bonfils S. Inhibitory effect of prolonged administration of long-acting somatostatin on gastrin-stimulated fundic epithelial cell growth in the rat. Digestion. 1982;24(4):246–255. doi: 10.1159/000198804. [DOI] [PubMed] [Google Scholar]
  9. Lennon J. R., Sircus W., Bloom S. R., Mitchell S. J., Polak J. M., Besser G. M., Hall R., Coy D. H., Kastin A. J., Schally A. V. Proceedings: Investigation and treatment of a recurrent vipoma. Gut. 1975 Oct;16(10):821–822. [PubMed] [Google Scholar]
  10. René E., Reyl F., Bonfils S. Intérêt thérapeutique de la somatostatine en gastroentérologie. Bases théoriques. Orientations pratiques. Gastroenterol Clin Biol. 1980 Oct;4(10):700–708. [PubMed] [Google Scholar]
  11. Ruskoné A., René E., Chayvialle J. A., Bonin N., Pignal F., Kremer M., Bonfils S., Rambaud J. C. Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera. Dig Dis Sci. 1982 May;27(5):459–466. doi: 10.1007/BF01295657. [DOI] [PubMed] [Google Scholar]
  12. Schusdziarra V., Grube D., Seifert H., Galle J., Etzrodt H., Beischer W., Haferkamp O., Pfeiffer E. F. Somatostatinoma syndrome. Clinical, morphological and metabolic features and therapeutic aspects. Klin Wochenschr. 1983 Jul 15;61(14):681–689. doi: 10.1007/BF01487613. [DOI] [PubMed] [Google Scholar]
  13. Sohier J., Jeanmougin M., Lombrail P., Passa P. Rapid improvement of skin lesions in glucagonomas with intravenous somatostatin infusion. Lancet. 1980 Jan 5;1(8158):40–40. doi: 10.1016/s0140-6736(80)90572-3. [DOI] [PubMed] [Google Scholar]
  14. Vallot T., Mignon M., Mazure R., Bonfils S. Evaluation of antisecretory drug therapy of Zollinger-Ellison syndrome (ZES) using 24-hour pH monitoring. Dig Dis Sci. 1983 Jul;28(7):577–584. doi: 10.1007/BF01299916. [DOI] [PubMed] [Google Scholar]
  15. Wood S. M., Kraenzlin M. E., Adrian T. E., Bloom S. R. Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut. 1985 May;26(5):438–444. doi: 10.1136/gut.26.5.438. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES